These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 36479082)
1. Intrahepatic cholangiocarcinoma: The role of liver transplantation, adjunctive treatments, and prognostic biomarkers. Connor AA; Kodali S; Abdelrahim M; Javle MM; Brombosz EW; Ghobrial RM Front Oncol; 2022; 12():996710. PubMed ID: 36479082 [TBL] [Abstract][Full Text] [Related]
2. Liver Transplantation for Intrahepatic Cholangiocarcinoma: What Are New Insights and What Should We Follow? Sun D; Lv G; Dong J Front Oncol; 2021; 11():841694. PubMed ID: 35127541 [TBL] [Abstract][Full Text] [Related]
4. Liver Transplantation for Unresectable Intrahepatic Cholangiocarcinoma: The Role of Sequencing Genetic Profiling. Gruttadauria S; Barbera F; Pagano D; Liotta R; Miraglia R; Barbara M; Bavetta MG; Cammà C; Petridis I; Di Carlo D; Conaldi PG; Di Francesco F Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885159 [TBL] [Abstract][Full Text] [Related]
5. Ablative Therapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis. Yousaf A; Kim JU; Eliahoo J; Taylor-Robinson SD; Khan SA J Clin Exp Hepatol; 2019; 9(6):740-748. PubMed ID: 31889756 [TBL] [Abstract][Full Text] [Related]
7. New Challenges in the Management of Cholangiocarcinoma: The Role of Liver Transplantation, Locoregional Therapies, and Systemic Therapy. Mauro E; Ferrer-Fàbrega J; Sauri T; Soler A; Cobo A; Burrel M; Iserte G; Forner A Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831586 [TBL] [Abstract][Full Text] [Related]
8. The Role of Surgical Resection and Liver Transplantation for the Treatment of Intrahepatic Cholangiocarcinoma. Panayotova G; Guerra J; Guarrera JV; Lunsford KE J Clin Med; 2021 May; 10(11):. PubMed ID: 34070772 [TBL] [Abstract][Full Text] [Related]
9. Liver resection and transplantation for intrahepatic cholangiocarcinoma. Mazzaferro V; Gorgen A; Roayaie S; Droz Dit Busset M; Sapisochin G J Hepatol; 2020 Feb; 72(2):364-377. PubMed ID: 31954498 [TBL] [Abstract][Full Text] [Related]
10. Incidence Trend and Competing Risk Analysis of Patients With Intrahepatic Cholangiocarcinoma: A Population-Based Study. Xing H; Tan B; Yang C; Zhang M Front Med (Lausanne); 2022; 9():846276. PubMed ID: 35433765 [TBL] [Abstract][Full Text] [Related]
11. Incidental Intra-Hepatic Cholangiocarcinoma and Hepatocholangiocarcinoma in Liver Transplantation: A Single-Center Experience. Serra V; Tarantino G; Guidetti C; Aldrovandi S; Cuoghi M; Olivieri T; Assirati G; De Ruvo N; Magistri P; Ballarin R; Di Benedetto F Transplant Proc; 2016 Mar; 48(2):366-9. PubMed ID: 27109957 [TBL] [Abstract][Full Text] [Related]
12. Orthotopic liver transplantation in combination with neoadjuvant therapy: a new paradigm in the treatment of unresectable intrahepatic cholangiocarcinoma. Rana A; Hong JC Curr Opin Gastroenterol; 2012 May; 28(3):258-65. PubMed ID: 22333563 [TBL] [Abstract][Full Text] [Related]
13. Targeting FGFR in intrahepatic cholangiocarcinoma [iCCA]: leading the way for precision medicine in biliary tract cancer [BTC]? Aitcheson G; Mahipal A; John BV Expert Opin Investig Drugs; 2021 Apr; 30(4):463-477. PubMed ID: 33678096 [No Abstract] [Full Text] [Related]
14. Third-line sunitinib treatment in a Li X; Gao L; Zhang L; Sun H; Gou H Cancer Biol Ther; 2020 Sep; 21(9):785-789. PubMed ID: 32552305 [TBL] [Abstract][Full Text] [Related]
16. Thrombospondin 1 and 2 along with PEDF inhibit angiogenesis and promote lymphangiogenesis in intrahepatic cholangiocarcinoma. Carpino G; Cardinale V; Di Giamberardino A; Overi D; Donsante S; Colasanti T; Amato G; Mennini G; Franchitto M; Conti F; Rossi M; Riminucci M; Gaudio E; Alvaro D; Mancone C J Hepatol; 2021 Dec; 75(6):1377-1386. PubMed ID: 34329660 [TBL] [Abstract][Full Text] [Related]
17. Intrahepatic Cholangiocarcinoma in the Liver Explant After Liver Transplantation: Histological Differentiation and Prognosis. Takahashi K; Obeid J; Burmeister CS; Bruno DA; Kazimi MM; Yoshida A; Abouljoud MS; Schnickel GT Ann Transplant; 2016 Apr; 21():208-15. PubMed ID: 27068242 [TBL] [Abstract][Full Text] [Related]
18. Chimeric immune checkpoint protein vaccines inhibit the tumorigenesis and growth of rat cholangiocarcinoma. Pan YR; Wu CE; Huang WK; Chen MH; Lan KH; Yeh CN Front Immunol; 2022; 13():982196. PubMed ID: 36341387 [TBL] [Abstract][Full Text] [Related]
19. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis. Clements O; Eliahoo J; Kim JU; Taylor-Robinson SD; Khan SA J Hepatol; 2020 Jan; 72(1):95-103. PubMed ID: 31536748 [TBL] [Abstract][Full Text] [Related]
20. Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma. Moeini A; Sia D; Bardeesy N; Mazzaferro V; Llovet JM Clin Cancer Res; 2016 Jan; 22(2):291-300. PubMed ID: 26405193 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]